Better, Faster, Stronger
Biomarkers

Converting PET/CT images into actionable quantitative information for research and diagnostic support.

Get a demo !

Our vision

Nova aid provides accurate and reliable biomarkers extracted by AI from PET/CT images to guide therapeutic decisions and research.

Immunotherapy is transforming oncology, but its effectiveness is hindered by unconventional modes of response. Standard imaging criteria are not suited to this therapeutic revolution and fail in evaluating treatment responses, leaving clinicians and researchers without reliable tools for monitoring patient responses. Our exclusive technology analyzes PET/CT images to extract all available information and predictive radiomic signatures. As a result, our AI models offer our partners a robust and reliable solution for optimizing treatment strategies and improving patient outcomes.

Our solutions rely on a high-quality proprietary dataset specific to metastatic lung cancer treated with immune checkpoint inhibitors.

About us

The team is made up of data and AI experts, all motivated to provide the necessary support to the fight against cancer through technology.

We are part of Euranova, a consulting firm and private R&D center. The Nova Aid solution is the result of the best of our healthcare services and our in-house research on the subject.

Data & AI expert

Private R&D center

Our private R&D center allows us to gain in-depth expertise that puts our solutions at the cutting edge of technology. This improves our skills in specialized areas and makes our solutions even more efficient and robust.

Research is an important vector for us, and our desire to innovate transforms our proofs of concept into real-world solutions.